Ameriprise’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$7K Sell
2022
Q1
$14K Sell
2021
Q4
$22K Sell
2021
Q3
$45K Buy
2021
Q2
$113K Buy
2021
Q1
$220K Sell
2020
Q4
$303K Sell
2020
Q3
$391K Sell
2020
Q2
$520K Buy
2020
Q1
$273K Sell
2019
Q4
$3.92M Buy
2019
Q3
Sell
2019
Q2
$102K Sell
2019
Q1
$141K Hold
2018
Q4
$74K Buy